News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
95,903 Results
Type
Article (5501)
Company Profile (55)
Press Release (90347)
Section
Business (32806)
Career Advice (219)
Deals (5285)
Drug Delivery (12)
Drug Development (16646)
Employer Resources (19)
FDA (1595)
Job Trends (2278)
News (53943)
Policy (2977)
Tag
2024 BioForest Digital (5)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
Academia (279)
Adcomms (2)
Allergies (5)
Alliances (7383)
ALS (8)
Alzheimer's disease (101)
Antibody-drug conjugate (ADC) (72)
Approvals (1622)
Artificial intelligence (32)
Autoimmune disease (4)
Automation (1)
Bankruptcy (27)
Best Places to Work (1867)
BIOSECURE Act (2)
Biosimilars (19)
Biotechnology (41)
Bladder cancer (16)
Brain cancer (12)
Breast cancer (91)
Cancer (772)
Cardiovascular disease (8)
Career advice (184)
Career pathing (2)
CAR-T (58)
Cell therapy (159)
Cervical cancer (3)
Clinical research (13243)
Collaboration (191)
Compensation (60)
Complete response letters (1)
COVID-19 (320)
CRISPR (14)
C-suite (49)
Cystic fibrosis (2)
Data (436)
Denatured (3)
Depression (4)
Diabetes (20)
Diagnostics (943)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (26)
Drug pricing (8)
Drug shortages (1)
Duchenne muscular dystrophy (13)
Earnings (14335)
Editorial (4)
Employer branding (4)
Employer resources (16)
Events (15841)
Executive appointments (147)
FDA (1783)
Featured Employer (9)
Friedreich's ataxia (1)
Funding (152)
Gene editing (28)
Gene therapy (33)
GLP-1 (108)
Government (351)
Guidances (7)
Healthcare (2820)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (25)
Indications (7)
Infectious disease (332)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (21)
Interviews (37)
IPO (2710)
IRA (7)
Job creations (469)
Job search strategy (150)
Kidney cancer (5)
Labor market (3)
Layoffs (89)
Leadership (2)
Legal (402)
Liver cancer (21)
Lung cancer (118)
Lymphoma (40)
Management (6)
Manufacturing (51)
MASH (7)
Medical device (994)
Medtech (994)
Mergers & acquisitions (2687)
Metabolic disorders (58)
Multiple sclerosis (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (4)
Neuroscience (152)
NextGen: Class of 2025 (803)
Non-profit (270)
Northern California (585)
Now hiring (5)
Obesity (34)
Opinion (31)
Ovarian cancer (38)
Pain (10)
Pancreatic cancer (36)
Parkinson's disease (7)
Partnered (3)
Patents (41)
Patient recruitment (14)
Peanut (2)
People (9719)
Pharmaceutical (8)
Phase I (6509)
Phase II (5982)
Phase III (3062)
Pipeline (268)
Podcasts (7)
Policy (12)
Postmarket research (110)
Preclinical (2061)
Press Release (28)
Prostate cancer (21)
Psychedelics (7)
Radiopharmaceuticals (103)
Rare diseases (38)
Real estate (785)
Recruiting (10)
Regulatory (2522)
Reports (10)
Research institute (355)
Resumes & cover letters (39)
RSV (2)
Schizophrenia (11)
Series A (39)
Series B (18)
Service/supplier (2)
Sickle cell disease (4)
Southern California (613)
Special edition (1)
Sponsored (2)
Startups (778)
Stomach cancer (3)
Supply chain (6)
The Weekly (4)
United States (3976)
Vaccines (81)
Venture capitalists (11)
Webinars (2)
Weight loss (17)
Women's health (1)
Worklife (1)
Date
Today (24)
Last 7 days (133)
Last 30 days (572)
Last 365 days (7450)
2025 (1234)
2024 (7679)
2023 (8724)
2022 (10427)
2021 (10425)
2020 (8614)
2019 (5946)
2018 (4545)
2017 (4860)
2016 (4043)
2015 (4694)
2014 (3140)
2013 (2386)
2012 (2817)
2011 (2834)
2010 (2441)
Location
Africa (78)
Alabama (5)
Arizona (20)
Asia (7085)
Australia (991)
California (1351)
Canada (327)
China (149)
Colorado (49)
Connecticut (46)
Delaware (40)
Europe (13205)
Florida (118)
Georgia (10)
Idaho (6)
Illinois (68)
India (3)
Indiana (46)
Japan (34)
Kansas (17)
Kentucky (7)
Louisiana (1)
Maine (5)
Maryland (110)
Massachusetts (795)
Michigan (27)
Minnesota (49)
Missouri (13)
Montana (2)
Nebraska (4)
Nevada (5)
New Hampshire (4)
New Jersey (295)
New York (271)
North Carolina (162)
Northern California (585)
Ohio (33)
Oklahoma (4)
Oregon (7)
Pennsylvania (176)
Rhode Island (4)
South America (109)
South Carolina (2)
Southern California (613)
Tennessee (7)
Texas (195)
Utah (16)
Virginia (16)
Washington D.C. (2)
Washington State (95)
Wisconsin (9)
95,903 Results for "solid biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solid Biosciences Announces Pricing of Underwritten Offering
February 18, 2025
·
5 min read
Press Releases
Solid Biosciences to Participate at Upcoming March 2025 Investor Conferences
March 6, 2025
·
2 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
1 min read
Press Releases
Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 6, 2025
·
14 min read
Press Releases
Solid Biosciences Added to the Nasdaq Biotechnology Index
December 24, 2024
·
1 min read
Press Releases
Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003
February 18, 2025
·
13 min read
Solid Biosciences Joins the Russell 3000® Index
Solid Biosciences Inc. announced that the Company has been added to the broad-market Russell 3000® Index as part of the annual reconstitution, effective at the open of US equity markets, Monday, July 1st 2024.
July 1, 2024
·
5 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025
February 5, 2025
·
1 min read
Press Releases
Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
Solid Biosciences to Present at the Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
1 of 9,591
Next
